Mitochondrial Metabolism

线粒体使用多种碳燃料来产生 ATP 和代谢物,包括由糖酵解产生的丙酮酸、谷氨酰胺等氨基酸和脂肪酸。这些碳燃料进入线粒体基质中的 TCA 循环,产生还原当量 NADH 和 FADH2,它们将电子传递到电子传递链。线粒体是复杂的细胞器,在细胞功能的许多方面发挥着重要作用,从新陈代谢到免疫调节和细胞死亡。线粒体积极参与各种细胞过程和分子相互作用,例如钙缓冲、脂质通量和细胞内信号传导。人们越来越认识到,线粒体功能障碍是许多疾病的标志,例如肥胖/糖尿病、癌症、心血管和神经退行性疾病。线粒体代谢 (Mitochondrial Metabolism) 是肿瘤进展的关键决定因素,它影响上皮-间质转化等功能。线粒体代谢和衍生的致癌代谢物塑造了表观遗传景观,从而改变了癌细胞的侵袭性特征。线粒体代谢的变化与肿瘤在治疗后的存活率有关。

Mitochondria use multiple carbon fuels to produce ATP and metabolites, including pyruvate, which is generated from glycolysis; amino acids such as glutamine; and fatty acids. These carbon fuels feed into the TCA cycle in the mitochondrial matrix to generate the reducing equivalents NADH and FADH2, which deliver their electrons to the electron transport chain. Mitochondria are complex organelles that play an important role in many facets of cellular function, from metabolism to immune regulation and cell death. Mitochondria are actively involved in a wide variety of cellular processes and molecular interactions, such as calcium buffering, lipid flux, and intracellular signaling. It is increasingly recognized that mitochondrial dysfunction is a hallmark of many diseases such as obesity/diabetes, cancer, cardiovascular and neurodegenerative diseases. Mitochondrial metabolism is a key determinant of tumor progression by impacting on functions such as epithelial-to-mesenchymal transition. Mitochondrial metabolism and derived oncometabolites shape the epigenetic landscape to alter aggressiveness features of cancer cells. Changes in mitochondrial metabolism are relevant for the survival of tumors in response to therapy.

共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MFN2 agonist-1

MFN2 agonist-1 (B-A/l) 能有效刺激线粒体融合蛋白 2 (MFN2) 缺陷细胞中的线粒体融合,并可逆转表达 CMT2A 突变体 MFN2 T105M 的培养小鼠神经元中线粒体“聚集”(静态线粒体聚集体的形成)并恢复线粒体运动性。

2230047-87-5
Agonist
98.84%
MFN2 agonist-1
Sperm motility agonist-2

Sperm motility agonist-2 (compound 797) 是一种可能通过影响线粒体功能发挥作用的精子活力激动剂,可用于不孕症及增强生育力的研究。

926079-67-6
Agonist
98.51%
Sperm motility agonist-2
THR-β agonist 9

THR-β agonist 9 是一种强效、选择性且对 His435 突变敏感的 THR-β 激动剂(EC50:3.2 nM),具有中等选择性(约 10 倍)以及对多种 His435 突变体(H435A、H435Y 和 H435R)良好的活化能力(EC50:134.2 nM 至 515.5 nM),具有研究血脂异常、代谢功能障碍相关脂肪性肝炎(MASH)或甲状腺激素耐药性(RTH)的潜力。

2920045-74-3
Agonist
THR-β agonist 9

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础